Australian Bodies Set Out Joint Position On Coronavirus
Follows Authorization From Competition Authority To Work Together
Executive Summary
Australia’s off-patent industry association, the GBMA, and local brand organization Medicines Australia have set out their plans for collaborating on supplying essential medicines amid the coronavirus pandemic. The move follows a recent temporary authorization by local competition regulator the ACCC that will allow the bodies to work more closely together.
You may also be interested in...
Australia Allows Industry Collaboration To Continue
Australia’s competition authority has extended the arrangements allowing local off-patent industry body the GBMA to closely collaborate with brand organization Medicines Australia to co-ordinate supply against the backdrop of the ongoing COVID-19 pandemic.
Medicines Must Be Designated As Priority Items, Says IGBA
Governments around the world should designate all medicines as ‘priority essential products’, the IGBA has urged, as a surge in demand coinciding with a reduction in the number of flights and rising freight costs are making it more difficult for suppliers to meet global requirements amid the coronavirus pandemic.
Australia Relaxes Competition Rules To Facilitate Coronavirus Response
Australia’s competition regulator, the ACCC, has granted a conditional dispensation to allow generics industry association the GBMA and brand body Medicines Australia to work together to help address the coronavirus pandemic by sharing information on stock, inventory, manufacturing and the supply chain. However, tender pricing will not be among the subjects discussed.